We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Tylenol Recall Spurred by High Levels of Compound
J&J Tylenol Recall Spurred by High Levels of Compound
August 16, 2011
Johnson & Johnson (J&J) subsidiary McNeil Consumer Healthcare is again recalling Tylenol products, this time for higher-than-expected levels of a compound.